Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ELCC 2018 banner

Abstract submission is closed


Date and time

 Abstract submission system opening

21 September 2017

  • Abstracts
  • Trial in Progress
  • Intent to submit LBA

8 January 2018, 21:00 CET (Central European Time)

 Late-breaking abstracts (LBA)

5 March 2018, 21:00 CET (Central European Time)

Outcome notifications

Outcome notifications are expected to be made available to first authors by the end of January 2018.

Late-breaking abstracts

Late-breaking abstracts may be submitted for high quality, new research findings with implications for clinical practice or understanding of disease processes. The work must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organisation prior to ELCC 2018.Only abstracts for which no conclusive data are available at the time of the abstract submission deadline of 8 January 2018 will be considered for late-breaking status.A preliminary abstract indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by 8 January 2018 and the intent to submit a late-breaking abstract check-box must be ticked.Submitters of preliminary versions receiving approval to proceed must submit the final LBA by 5 March 2018, 21:00 CET (Central European Time).

Trial in Progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ELCC 2018.It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design


  • Recruitment must have already begun or have been completed by the abstract submission deadline of 8 January 2018.
  • Abstracts including results or preliminary data will be rejected.
  • Authors of ‘encore’ TiP abstract submissions must supply information regarding the original presentation, indicating the name of the meeting and publication number. The first author will be responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s).

Trial in Progress abstracts will be accepted for Poster outcome only.

Presentation of accepted abstracts

The ELCC 2018 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

  • Proffered Paper (oral presentation) – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Poster Discussion – Presentation and analysis by an invited speaker highlighting important findings within a disease type or about a common theme plus interactive audience discussion.
  • Poster – An important method for communicating details of scientific research, posters will be on display for the duration of the Congress.

Publication schedule of accepted abstracts 

  • Abstracts accepted for presentation during ELCC 2018 (Proffered Paper, Poster Discussion and Poster) and for publication in the ELCC 2018 Abstract Book, will be published online on the ELCC 2018 Website on 4 April 2018.
  • Late-breaking abstracts and abstracts selected for the official ELCC 2018 Press Programme will be made public at the beginning of the press Congress or scientific session during which they are presented, whichever comes first.

Abstracts accepted as

Publication schedule

Regular submission

  • Proffered Paper (suffix ‘O’)
  • Poster Discussion (suffix ‘PD’)
  • Poster (suffix ‘P’)

4 April 2018, 12:00 Central European Summer Time (CEST)

Late-breaking abstracts 
prefix ‘LBA’ and abstracts selected for the official ELCC 2018 Press Programme (additional suffix ‘_PR’)

Beginning of the official ELCC 2018 Press Conference or the official Congress session during which they are presented, whichever comes first

Travel grants

A restricted number of travel grants to ELCC 2018 are available, upon application, to first author (= presenter) of candidates under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by the ELCC 2018 Scientific Committee on a competitive basis from among the accepted abstracts.To apply for a travel grant, the following documents must be received by the ELCC Secretariat c/o the ESMO Congress Department on or before 8 January 2018:

  1. A letter of introduction by the applicant. Please include the following general information
    • How relevant are the topics presented during this Congress to your current practice and research?
    • Have you attended any event on a similar topic in the last 3 years?
    • How do you believe your attendance at this Congress will help you improve your knowledge in the field and your professional development?
    • How do you consider that the findings published in your abstract make a relevant contribution to the topics presented during this Congress?
    • Have you recently been awarded an ESMO travel grant? If yes, for which event?
  2. A copy of the submitted abstract (the applicant must be the first author and presenter)
  3. A readable photocopy of either identity card or passport
  4. A short curriculum vitae (maximum 2 pages)

Documentation must be sent by e-mail to travelgrants@esmo.org  The ELCC 2018 organisers will provide the recipients with a subsidised travel ticket, subsidised accommodation and Congress registration.Travel grant recipients must submit a report detailing the benefits of participating in ELCC 2018 by 15 June 2018.Incomplete applications will not be considered.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings